Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on first line management of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Jessicca Lin as the primary speaker and Dr. T. Raja, Dr. Amit Rauthan, Dr. B. K. Smruti and many other panelists who will share the important facts associated with first line management of ALK positive lung cancer.
Starting with the case scenario of non-small cell lung cancer, Dr Jessica has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, the panel discussion will give more knowledge.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?
3.
New First-Line Option for Advanced ALK-Positive Lung Cancer
4.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
5.
Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.
1.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
2.
Cancer Stem Cells: The Seeds of Tumorigenesis and Recurrence
3.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
4.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
5.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
5.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation